Aukera Therapeutics
PrivateLast Round
Seed
Dec 11, 2025
Total Funding Raised
$6.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aukera Therapeutics is a biotechnology company developing therapies for mTOR-related disorders such as tuberous sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aukera Therapeutics Comparables
Compare Aukera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aeovian Pharmaceuticals | 84% | |
| Cambrian Bio | 78% | |
| Johnson & Johnson | 74% |
Aukera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 11, 2025 | ||||
| Grant | Oct 19, 2022 | ||||
| Accelerator | Feb 21, 2022 |
Aukera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Seed |
| BaseLaunch | Accelerator |
| Venture Kick | Grant |
| Zurcher Kantonalbank | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 11, 2025
$6M raised from Zurcher Kantonalbank and Kickfund.
- Feb 21, 2022
$540K raised from BaseLaunch
Aukera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aukera Therapeutics's valuation, stock price, and market status.
Is Aukera Therapeutics a public or private company?
Aukera Therapeutics is a private company.
What is the current stock price of Aukera Therapeutics?
Aukera Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Aukera Therapeutics worth (valuation)?
Valuation information for Aukera Therapeutics is not publicly available.
Can I buy Aukera Therapeutics stock?
Aukera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aukera Therapeutics's last funding round?
Funding round information for Aukera Therapeutics is not publicly available.
Who are the main investors in Aukera Therapeutics?
Investor information for Aukera Therapeutics is not publicly disclosed.
Will Aukera Therapeutics IPO soon?
No public IPO plans have been announced for Aukera Therapeutics.
How can I track Aukera Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aukera Therapeutics's secondary market activity and sign up for updates.